Basic Information
RNALocate ID: | RLID:11002365 |
RNA Symbol: | hsa-miR-301a-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-301a |
RNA ID: | miRBase:MIMAT0000688 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21505438 |
Tissue/Cell Line: | Primary dendritic cells|T cell line (J77) |
Method: | Microarray |
Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001991 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001992 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001993 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001994 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11002364 | Exosome | Serum | 18589210 |
RLID:11002366 | Exosome | Renal cancer cells | 21670082 |
RLID:11002367 | Exosome | Brain tissue | 23382797 |
RLID:11002368 | Exosome | Plasma | 23663360 |
RLID:11002369 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002370 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
RLID:11002371 | Extracellular vesicle | Plasma | 32498409 |
RLID-D:11000112 | Exosome | Endothelial cells|Mast cells | |
RLID-D:11000400 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-301a-3p | Oral squamous cell carcinoma | MNDR-E-MI-35721 |
MNDR | hsa-miR-301a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-35722 |
MNDR | hsa-miR-301a-3p | Follicular lymphoma | MNDR-E-MI-35723 |
MNDR | hsa-miR-301a-3p | Small intestinal neuroendocrine tumor | MNDR-E-MI-35724 |
MNDR | hsa-miR-301a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-35725 |
MNDR | hsa-miR-301a-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-35726 |
MNDR | hsa-miR-301a-3p | Lymphoma | MNDR-E-MI-35727 |
MNDR | hsa-miR-301a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-35728 |
MNDR | hsa-miR-301a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-35729 |
MNDR | hsa-miR-301a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-35730 |
MNDR | hsa-miR-301a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-35731 |
MNDR | hsa-miR-301a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-35732 |
MNDR | hsa-miR-301a-3p | Breast cancer luminal | MNDR-E-MI-35733 |
MNDR | hsa-miR-301a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-35734 |
MNDR | hsa-miR-301a-3p | Small intestine cancer | MNDR-E-MI-35735 |
MNDR | hsa-miR-301a-3p | Prostate cancer | MNDR-E-MI-35736 |
MNDR | hsa-miR-301a-3p | Gastric cancer | MNDR-E-MI-35737 |
MNDR | hsa-miR-301a-3p | Gastric lymphoma | MNDR-E-MI-35738 |
MNDR | hsa-miR-301a-3p | Alzheimer disease | MNDR-E-MI-35739 |
MNDR | hsa-miR-301a-3p | Intracranial aneurysm | MNDR-E-MI-35740 |
MNDR | hsa-miR-301a-3p | Esophageal carcinoma | MNDR-E-MI-35741 |
MNDR | hsa-miR-301a-3p | Dysautonomia familial | MNDR-E-MI-35742 |
MNDR | hsa-miR-301a-3p | Seizures | MNDR-E-MI-35743 |
MNDR | hsa-miR-301a-3p | Head and neck cancer | MNDR-E-MI-35744 |
MNDR | hsa-miR-301a-3p | Vogt-koyanagi-harada disease | MNDR-E-MI-35745 |
MNDR | hsa-miR-301a-3p | Leukemia | MNDR-E-MI-35746 |
MNDR | hsa-miR-301a-3p | Cardiovascular disease | MNDR-E-MI-35747 |
MNDR | hsa-miR-301a-3p | Lung cancer | MNDR-E-MI-35748 |
MNDR | hsa-miR-301a-3p | Parkinson disease | MNDR-E-MI-35749 |
MNDR | hsa-miR-301a-3p | Basal-like breast cancer | MNDR-E-MI-35750 |
MNDR | hsa-miR-301a-3p | Thyroid cancer | MNDR-E-MI-35751 |
MNDR | hsa-miR-301a-3p | Pancreatic cancer | MNDR-E-MI-35752 |
MNDR | hsa-miR-301a-3p | Melanoma | MNDR-E-MI-35753 |
MNDR | hsa-miR-301a-3p | Rectum adenocarcinoma | MNDR-E-MI-35754 |
MNDR | hsa-miR-301a-3p | Nephroblastoma | MNDR-E-MI-35755 |
MNDR | hsa-miR-301a-3p | Colon cancer | MNDR-E-MI-35756 |
MNDR | hsa-miR-301a-3p | Colon adenocarcinoma | MNDR-E-MI-35757 |
MNDR | hsa-miR-301a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-35758 |
MNDR | hsa-miR-301a-3p | Familial ovarian cancer | MNDR-E-MI-35759 |
MNDR | hsa-miR-301a-3p | Laryngeal squamous cell carcinoma | MNDR-E-MI-35760 |
MNDR | hsa-miR-301a-3p | Carcinoma ductal breast | MNDR-E-MI-35761 |
MNDR | hsa-miR-301a-3p | Glioblastoma | MNDR-E-MI-35762 |
MNDR | hsa-miR-301a-3p | Glioma | MNDR-E-MI-35763 |
MNDR | hsa-miR-301a-3p | Central nervous system lymphoma | MNDR-E-MI-35764 |
MNDR | hsa-miR-301a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-35765 |
MNDR | hsa-miR-301a-3p | Epilepsy temporal lobe | MNDR-E-MI-35766 |
MNDR | hsa-miR-301a-3p | Osteosarcoma | MNDR-E-MI-35767 |
MNDR | hsa-miR-301a-3p | Liposarcoma | MNDR-E-MI-35768 |
MNDR | hsa-miR-301a-3p | Breast carcinoma | MNDR-E-MI-35769 |
MNDR | hsa-miR-301a-3p | Uterine cancer | MNDR-E-MI-35770 |
MNDR | hsa-miR-301a-3p | Gastric adenocarcinoma | MNDR-E-MI-35771 |
MNDR | hsa-miR-301a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-35772 |
MNDR | hsa-miR-301a-3p | Lung squamous cell carcinoma | MNDR-E-MI-35773 |
MNDR | hsa-miR-301a-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-35774 |
MNDR | hsa-miR-301a-3p | Lung adenocarcinoma | MNDR-E-MI-35775 |
MNDR | hsa-miR-301a-3p | Adrenocortical cancer | MNDR-E-MI-35776 |
MNDR | hsa-miR-301a-3p | Ovarian carcinoma | MNDR-E-MI-35777 |
MNDR | hsa-miR-301a-3p | Bladder urothelial carcinoma | MNDR-E-MI-35778 |
MNDR | hsa-miR-301a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-35779 |
MNDR | hsa-miR-301a-3p | Carcinoma renal cell | MNDR-E-MI-35780 |
MNDR | hsa-miR-301a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-35781 |
MNDR | hsa-miR-301a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-35782 |
MNDR | hsa-miR-301a-3p | Cholangiocarcinoma | MNDR-E-MI-35783 |
MNDR | hsa-miR-301a-3p | Esophageal cancer | MNDR-E-MI-35784 |
MNDR | hsa-miR-301a-3p | Lung small cell carcinoma | MNDR-E-MI-35785 |
MNDR | hsa-miR-301a-3p | Synovial sarcoma | MNDR-E-MI-35786 |
MNDR | hsa-miR-301a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-35787 |
MNDR | hsa-miR-301a-3p | Testicular germ cell cancer | MNDR-E-MI-35788 |
MNDR | hsa-miR-301a-3p | Fibromyalgia | MNDR-E-MI-35789 |
MNDR | hsa-miR-301a-3p | Pulmonary hypertension | MNDR-E-MI-35790 |
MNDR | hsa-miR-301a-3p | Breast invasive carcinoma | MNDR-E-MI-35791 |
MNDR | hsa-miR-301a-3p | Hepatocellular carcinoma | MNDR-E-MI-35792 |
MNDR | hsa-miR-301a-3p | Familiar ovarian carcinoma | MNDR-E-MI-35793 |
MNDR | hsa-miR-301a-3p | Rheumatoid arthritis | MNDR-E-MI-35794 |
MNDR | hsa-miR-301a-3p | T-cell leukemia | MNDR-E-MI-35795 |
MNDR | hsa-miR-301a-3p | Malignant pleural mesothelioma | MNDR-E-MI-35796 |
MNDR | hsa-miR-301a-3p | Retinoblastoma | MNDR-E-MI-35797 |
MNDR | hsa-miR-301a-3p | Hodgkin lymphoma | MNDR-E-MI-35798 |
MNDR | hsa-miR-301a-3p | Tonsil cancer | MNDR-E-MI-35799 |
MNDR | hsa-miR-301a-3p | Colorectal cancer | MNDR-E-MI-35800 |
MNDR | hsa-miR-301a-3p | Nasopharynx carcinoma | MNDR-E-MI-35801 |
MNDR | hsa-miR-301a-3p | Multiple myeloma | MNDR-E-MI-35802 |
MNDR | hsa-miR-301a-3p | Acute lymphocytic leukemia | MNDR-E-MI-35803 |
MNDR | hsa-miR-301a-3p | Ependymoma | MNDR-E-MI-35804 |
MNDR | hsa-miR-301a-3p | Nasopharyngeal cancer | MNDR-E-MI-35805 |
MNDR | hsa-miR-301a-3p | Prostatic neoplasms | MNDR-E-MI-35806 |
MNDR | hsa-miR-301a-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-35807 |
MNDR | hsa-miR-301a-3p | Venous thromboembolism | MNDR-E-MI-35808 |
MNDR | hsa-miR-301a-3p | Chronic pain | MNDR-E-MI-35809 |
MNDR | hsa-miR-301a-3p | Stroke lacunar | MNDR-E-MI-35810 |
MNDR | hsa-miR-301a-3p | Breast cancer her3+ negative | MNDR-E-MI-35811 |
MNDR | hsa-miR-301a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-35812 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ADCY3 | Homo sapiens | RR00044354 |
TOP